CD8A and neoplasm: In particular, we find that tumor antigen is selectively taken up by cDC2, rather than cDC1, which would be expected to skew the forthcoming adaptive immune response away from the generation of CD8 + T cells and Th1, and toward Th2, Th17, or Treg specification, thus impairing tumor clearance.